240 related articles for article (PubMed ID: 2523611)
1. Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma.
Peeling WB
Urology; 1989 May; 33(5 Suppl):45-52. PubMed ID: 2523611
[TBL] [Abstract][Full Text] [Related]
2. A comparison of Zoladex and DES in the treatment of advanced prostate cancer: results of a randomized, multicenter trial.
Citrin DL; Resnick MI; Guinan P; al-Bussam N; Scott M; Gau TC; Kennealey GT
Prostate; 1991; 18(2):139-46. PubMed ID: 1826048
[TBL] [Abstract][Full Text] [Related]
3. Interim report of a randomized trial comparing Zoladex 3.6 mg depot with diethylstilbestrol 3 mg/day in advanced prostate cancer. The West Midlands Urology Research Group.
Emtage LA; Trethowan C; Hilton C; Kelly K; Blackledge GR
Am J Clin Oncol; 1988; 11 Suppl 2():S173-5. PubMed ID: 2977273
[TBL] [Abstract][Full Text] [Related]
4. A phase III open randomized study of Zoladex 3.6 mg depot vs. DES 3 mg per day in untreated advanced prostate cancer: a West Midlands Urological Research Group Study.
Emtage LA; Trethowan C; Kelly K; Arkell D; Wallace DM; Hughes M; Hay A; Blacklock R; Jones M; Rouse A
Prog Clin Biol Res; 1989; 303():47-52. PubMed ID: 2528739
[No Abstract] [Full Text] [Related]
5. A comparison between surgical orchidectomy and the LHRH agonist 'Zoladex' (ICI 188630) in the treatment of metastatic cancer of the prostate.
Peeling WB
Prog Clin Biol Res; 1989; 303():41-5. PubMed ID: 2528738
[No Abstract] [Full Text] [Related]
6. Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma.
Chodak GW
Urology; 1989 May; 33(5 Suppl):42-4. PubMed ID: 2523610
[TBL] [Abstract][Full Text] [Related]
7. Phase III randomised study of zoladex versus stilboestrol in the treatment of advanced prostate cancer.
Waymont B; Lynch TH; Dunn JA; Emtage LA; Arkell DG; Wallace DM; Blackledge GR
Br J Urol; 1992 Jun; 69(6):614-20. PubMed ID: 1386272
[TBL] [Abstract][Full Text] [Related]
8. Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma.
Kaisary AV; Tyrrell CJ; Peeling WB; Griffiths K
Br J Urol; 1991 May; 67(5):502-8. PubMed ID: 1828183
[TBL] [Abstract][Full Text] [Related]
9. [Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].
Usami M; Kotake T; Matsuda M; Okajima E; Osafune M; Akaza H; Niijima T; Aso Y; Araki T; Itatani H
Hinyokika Kiyo; 1988 Oct; 34(10):1853-63. PubMed ID: 2977527
[TBL] [Abstract][Full Text] [Related]
10. Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group.
Soloway MS; Chodak G; Vogelzang NJ; Block NL; Schellhammer PF; Smith JA; Scott M; Kennealey G; Gau TC
Urology; 1991 Jan; 37(1):46-51. PubMed ID: 1824732
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation.
Kreis W; Ahmann FR; Jordan VC; de Haan H; Scott M
Br J Urol; 1988 Oct; 62(4):352-4. PubMed ID: 2973364
[TBL] [Abstract][Full Text] [Related]
12. A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate.
Iversen P; Christensen MG; Friis E; Hornbøl P; Hvidt V; Iversen HG; Klarskov P; Krarup T; Lund F; Mogensen P
Cancer; 1990 Sep; 66(5 Suppl):1058-66. PubMed ID: 2144207
[TBL] [Abstract][Full Text] [Related]
13. Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer?
Fernandez del Moral P; Litjens TT; Weil EH; Debruyne FM
Urology; 1988 Aug; 32(2):137-40. PubMed ID: 2969641
[TBL] [Abstract][Full Text] [Related]
14. U.K. trials of treatment for M1 prostatic cancer. The LH-RH analogue Zoladex vs. orchidectomy.
Ryan PG; Peeling WB
Am J Clin Oncol; 1988; 11 Suppl 2():S169-72. PubMed ID: 2977272
[TBL] [Abstract][Full Text] [Related]
15. Zoladex (ICI 118,630): clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinoma.
Murphy GP; Greco JM; Chin JL; Huben RP; Scott M; deHaan HA
Urology; 1987 Feb; 29(2):185-90. PubMed ID: 2949417
[TBL] [Abstract][Full Text] [Related]
16. LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II study.
Iversen P; Rose C; Stage JG; Iversen HG; Hansen RI; Hvidt V; Mogensen P; Pedersen T; Hansen JB
Scand J Urol Nephrol; 1989; 23(3):177-83. PubMed ID: 2529629
[TBL] [Abstract][Full Text] [Related]
17. Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86.
Iversen P; Suciu S; Sylvester R; Christensen I; Denis L
Cancer; 1990 Sep; 66(5 Suppl):1067-73. PubMed ID: 2144208
[TBL] [Abstract][Full Text] [Related]
18. Zoladex and flutamide vs orchidectomy: a phase III EORTC 30853 trial. EORTC Urological Group.
Carvalho AP; de Moura JL; Denis L; Newling D; Smith P; Bono A; Sylvester R; De Pauw M; Ongena P
Prog Clin Biol Res; 1989; 303():129-43. PubMed ID: 2528736
[No Abstract] [Full Text] [Related]
19. Zoladex and flutamide versus bilateral orchiectomy. A randomized phase III EORTC 30853 study. The EORTC GU Group.
Keuppens F; Denis L; Smith P; Carvalho AP; Newling D; Bond A; Sylvester R; De Pauw M; Vermeylen K; Ongena P
Cancer; 1990 Sep; 66(5 Suppl):1045-57. PubMed ID: 2144206
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with advanced cancer of the prostate: phase III trial, zoladex against castration; a study of the British Prostate Group.
Turkes AO; Peeling WB; Griffiths K
J Steroid Biochem; 1987; 27(1-3):543-9. PubMed ID: 2961938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]